Champions Oncology(CSBR) - 2026 Q2 - Quarterly Report
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-11504 CHAMPIONS ONCOLOGY, INC. For the quarterly period ended October 31, 2025 Or (Exact name of registrant as defined in its charter) (Former name, former address and former fiscal year, if chan ...